Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial (vol 39, pg 1972, 2016)

Aroda Vanita R.; Rosenstock Julio; Wysham Carol; Unger Jeffrey; Bellido Diego; Gonzalez-Galvez Guillermo; Takami Akane; Guo Hailing; Niemoeller Elisabeth; Souhami Elisabeth; Bergenstal Richard M.

首页> 外文期刊>Diabetes care >Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial (vol 39, pg 1972, 2016)

【24h】

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial (vol 39, pg 1972, 2016)

机译：Lixilan的疗效和安全性，胰岛素冰柱的可滴定定义与Lixisenatide在2型糖尿病中，基础胰岛素和二甲双胍（Metformin）不足：Lixilan-L随机试验（Vol 39，PG 1972,2016）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Diabetes care》 |2017年第6期|共1页
作者
Aroda Vanita R.; Rosenstock Julio; Wysham Carol; Unger Jeffrey; Bellido Diego; Gonzalez-Galvez Guillermo; Takami Akane; Guo Hailing; Niemoeller Elisabeth; Souhami Elisabeth; Bergenstal Richard M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial (vol 39, pg 1972, 2016) [J] . Aroda Vanita R., Rosenstock Julio, Wysham Carol, Diabetes care . 2017,第6期

机译：Lixilan的疗效和安全性，胰岛素冰柱的可滴定定义与Lixisenatide在2型糖尿病中，基础胰岛素和二甲双胍（Metformin）不足：Lixilan-L随机试验（Vol 39，PG 1972,2016）
2. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial [J] . Rosenstock Julio, Diamant Michaela, Aroda Vanita R., Diabetes care . 2016,第9期

机译：二甲双胍单药治疗控制不佳的2型糖尿病患者利西拉来定与胰岛素甘草碱的可滴定固定比例联合利西拉来的疗效和安全性：利西兰概念验证的随机试验
3. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial [J] . Rosenstock Julio, Aronson Ronnie, Grunberger George, Diabetes care . 2016,第11期

机译：LixiLan的可滴定固定比例胰岛素对照与口服药物控制不充分的2型糖尿病的利西拉肽，利西拉肽和利西拉肽单组分的可计量固定比例组合的益处：LixiLan-O随机试验
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Erratum. Efficacy and Safety of LixiLan a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980 [O] . Vanita R. Aroda, Julio Rosenstock, Carol Wysham, 2017

机译：勘误表。 LixiLan的有效性和安全性胰岛素甘草碱加Lixisenatide的可滴定固定比例联合治疗对基础胰岛素和二甲双胍控制不足的2型糖尿病：LixiLan-L随机试验。糖尿病护理2016; 39：1972–1980
7. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial [O] . Julio Rosenstock, Michaela Diamant, Vanita R. Aroda, 2016

机译：Lixilan的功效和安全性，Lixisenatide和胰岛素狼甘蓝的滴定定义组合，与2型糖尿病患者在二甲双胍单疗法上不充分控制：Lixilan概念的随机试验

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial (vol 39, pg 1972, 2016)

著录项

相似文献

相关主题

期刊订阅